Early Blood Marker Identified for Lung Cancer Risk Assessment

Prostate-specific antigen, commonly known as PSA, is a protein produced by cells in the prostate gland. This protein can be measured through a simple blood test that is widely used to screen for prostate conditions, including prostate cancer, benign prostatic hyperplasia, and prostatitis. The PSA test measures the amount of this protein present in the bloodstream, with results typically reported in nanograms per milliliter. While PSA is normally present in small amounts in the blood, elevated levels may indicate various prostate conditions that require further investigation.

Healthcare providers typically recommend PSA testing for men over the age of 50, though those with a family history of prostate cancer or other risk factors may need to begin screening earlier. The test is usually performed as part of routine health examinations or when symptoms suggest possible prostate problems. Before the test, patients may be advised to avoid certain activities that can temporarily raise PSA levels, such as vigorous exercise, sexual activity, or bicycle riding for 24 to 48 hours prior to the blood draw. Some medical procedures involving the prostate can also affect PSA levels and should be discussed with a healthcare provider.

PSA levels are generally interpreted based on age-specific reference ranges, as PSA naturally increases with age. Generally, PSA levels below 4 nanograms per milliliter are considered normal for most men, though some experts suggest lower thresholds. Levels between 4 and 10 are considered borderline and may warrant additional testing, while levels above 10 indicate a higher probability of prostate cancer. However, it is important to note that elevated PSA levels do not automatically indicate cancer, as non-cancerous conditions can also cause increases. Conversely, some men with prostate cancer may have normal PSA levels, which is why the test is often used in combination with other diagnostic methods.

When PSA levels are elevated or rising over time, healthcare providers may recommend additional tests such as a digital rectal examination, repeat PSA testing, or more advanced imaging studies. In some cases, a prostate biopsy may be necessary to determine whether cancer cells are present. The PSA test remains a valuable screening tool, but interpretation of results requires careful consideration of individual patient factors, symptoms, and medical history. Regular monitoring of PSA levels over time can provide important information about changes in prostate health and help guide appropriate medical decisions.